Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
31860BR Ecology & Evolutionary Biology Position Overview The Choi lab (https://jychoilab.github.io/) at the University of Kansas seeks an assistant researcher with interests and experience in
-
-supervised by Prof. Marianne Fyhn: https://www.mn.uio.no/ibv/personer/vit/rafalc/ https://www.mn.uio.no/ibv/english/people/aca/mariafy/ Jarli og Jordan/UiO via Unsplash Jarli og Jordan/UiO What skills
-
experience with genotypic and phenotypic analyses • RT PCR and qPCR • scRNA-seq technologies • FACs analysis • Immunohistochemistry and tissue sectioning • Biochemical Assays
-
, and Nursing, including regional campuses in Peoria, Quad Cities, Rockford, Springfield, and Urbana. UI Health is dedicated to the pursuit of health equity. Learn more: https://hospital.uillinois.edu
-
electrophoresis, fluorescence microscopy, PCR and Real-Time PCR). Teaching experience in conducting laboratory classes at a university. Experience in the implementation of research grants as a principal
-
role of inflammation in this response. These immune responses can cause severe transfusion reactions and significantly limit the availability of compatible blood for future transfusions. https
-
reception/preparation for cytometry, T cell culture, mouse research colony handling, molecular biology (RT-PCR, CRISPR, cloning, gel eletrophoresis, transfections, DNA/RNA extraction for transcriptomic
-
to create impact on a global scale. For more information on the Lee laboratory: https://www.lsi.umich.edu/science/our-labs/t-lee-lab Responsibilities* Mouse colony management which includes the following
-
University of California, Los Angeles | Los Angeles, California | United States | about 14 hours ago
proteins Perform PCR, qPCR, ddPCR, ELISA and multiparametric flow cytometry to assist on-going specific research projects. Culture adhered and non-adherent mammalian cells (T-cells), preparing media
-
: Synthesis of building blocks for evolution of polymerases to revolutionize PCR-based technologies, enabling innovative cancer-targeted therapies. Post 2 : Development of antisense oligonucleotides and